nodes	percent_of_prediction	percent_of_DWPC	metapath
Ganciclovir—SLC22A1—prostate cancer	0.436	1	CbGaD
Ganciclovir—SLC22A8—Conjugated Estrogens—prostate cancer	0.0696	0.231	CbGbCtD
Ganciclovir—SLC22A1—Estradiol—prostate cancer	0.0619	0.206	CbGbCtD
Ganciclovir—SLC22A8—Estradiol—prostate cancer	0.0611	0.203	CbGbCtD
Ganciclovir—SLC22A7—Docetaxel—prostate cancer	0.0598	0.199	CbGbCtD
Ganciclovir—SLC22A6—Conjugated Estrogens—prostate cancer	0.0485	0.161	CbGbCtD
Ganciclovir—SLC22A1—Abacavir transmembrane transport—SLC22A3—prostate cancer	0.00135	0.0636	CbGpPWpGaD
Ganciclovir—SLC22A7—Organic cation/anion/zwitterion transport—SLC22A3—prostate cancer	0.00115	0.0543	CbGpPWpGaD
Ganciclovir—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A3—prostate cancer	0.000969	0.0457	CbGpPWpGaD
Ganciclovir—SLC22A7—Organic cation/anion/zwitterion transport—SLC22A1—prostate cancer	0.00094	0.0443	CbGpPWpGaD
Ganciclovir—SLC22A1—Organic cation transport—SLC22A3—prostate cancer	0.000927	0.0437	CbGpPWpGaD
Ganciclovir—Aciclovir—SLC22A1—prostate cancer	0.00084	1	CrCbGaD
Ganciclovir—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A3—prostate cancer	0.000809	0.0381	CbGpPWpGaD
Ganciclovir—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A1—prostate cancer	0.00079	0.0372	CbGpPWpGaD
Ganciclovir—SLC22A1—Abacavir transport and metabolism—SLC22A3—prostate cancer	0.000775	0.0365	CbGpPWpGaD
Ganciclovir—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A1—prostate cancer	0.000659	0.0311	CbGpPWpGaD
Ganciclovir—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—ACHE—prostate cancer	0.00064	0.0302	CbGpPWpGaD
Ganciclovir—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A3—prostate cancer	0.000628	0.0296	CbGpPWpGaD
Ganciclovir—SLC22A7—Fluoropyrimidine Activity—UMPS—prostate cancer	0.000617	0.0291	CbGpPWpGaD
Ganciclovir—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—COMT—prostate cancer	0.000446	0.021	CbGpPWpGaD
Ganciclovir—SLC22A7—Fluoropyrimidine Activity—CYP2A6—prostate cancer	0.000374	0.0176	CbGpPWpGaD
Ganciclovir—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A1—prostate cancer	0.000358	0.0169	CbGpPWpGaD
Ganciclovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A1—prostate cancer	0.000301	0.0142	CbGpPWpGaD
Ganciclovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A1—prostate cancer	0.000251	0.0118	CbGpPWpGaD
Ganciclovir—SLC22A7—Fluoropyrimidine Activity—TYMS—prostate cancer	0.000244	0.0115	CbGpPWpGaD
Ganciclovir—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—prostate cancer	0.000231	0.0109	CbGpPWpGaD
Ganciclovir—SLC22A7—Fluoropyrimidine Activity—ERCC2—prostate cancer	0.000226	0.0107	CbGpPWpGaD
Ganciclovir—SLC22A7—Fluoropyrimidine Activity—MTHFR—prostate cancer	0.000213	0.01	CbGpPWpGaD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—SLC7A1—prostate cancer	0.000206	0.00971	CbGpPWpGaD
Ganciclovir—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A1—prostate cancer	0.000195	0.00921	CbGpPWpGaD
Ganciclovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—prostate cancer	0.000194	0.00915	CbGpPWpGaD
Ganciclovir—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A1—prostate cancer	0.000188	0.00887	CbGpPWpGaD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC7A1—prostate cancer	0.000173	0.00816	CbGpPWpGaD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—SLC39A1—prostate cancer	0.000163	0.00768	CbGpPWpGaD
Ganciclovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—prostate cancer	0.000162	0.00764	CbGpPWpGaD
Ganciclovir—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A1—prostate cancer	0.000158	0.00746	CbGpPWpGaD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC7A1—prostate cancer	0.000145	0.00681	CbGpPWpGaD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC39A1—prostate cancer	0.000137	0.00645	CbGpPWpGaD
Ganciclovir—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A1—prostate cancer	0.000132	0.00622	CbGpPWpGaD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—SLC12A2—prostate cancer	0.000129	0.0061	CbGpPWpGaD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—SLC26A4—prostate cancer	0.000129	0.0061	CbGpPWpGaD
Ganciclovir—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—prostate cancer	0.000126	0.00593	CbGpPWpGaD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC39A1—prostate cancer	0.000114	0.00538	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC7A1—prostate cancer	0.000112	0.00529	CbGpPWpGaD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC12A2—prostate cancer	0.000109	0.00513	CbGpPWpGaD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC26A4—prostate cancer	0.000109	0.00513	CbGpPWpGaD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—SLC22A3—prostate cancer	0.000105	0.00495	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.000105	0.00493	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—KCNN3—prostate cancer	9.87e-05	0.00465	CbGpPWpGaD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC26A4—prostate cancer	9.08e-05	0.00428	CbGpPWpGaD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC12A2—prostate cancer	9.08e-05	0.00428	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC39A1—prostate cancer	8.88e-05	0.00418	CbGpPWpGaD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC22A3—prostate cancer	8.82e-05	0.00416	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC7A1—prostate cancer	8.8e-05	0.00415	CbGpPWpGaD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	8.56e-05	0.00403	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC39A1—prostate cancer	8.28e-05	0.0039	CbGpPWpGaD
Ganciclovir—SLC22A7—Fluoropyrimidine Activity—TP53—prostate cancer	8.08e-05	0.00381	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—RRAS—prostate cancer	7.96e-05	0.00375	CbGpPWpGaD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC22A3—prostate cancer	7.36e-05	0.00347	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC7A1—prostate cancer	7.34e-05	0.00346	CbGpPWpGaD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	7.19e-05	0.00339	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC26A4—prostate cancer	7.05e-05	0.00332	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC12A2—prostate cancer	7.05e-05	0.00332	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC39A1—prostate cancer	6.96e-05	0.00328	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—CYP7B1—prostate cancer	6.75e-05	0.00318	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC26A4—prostate cancer	6.57e-05	0.0031	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC12A2—prostate cancer	6.57e-05	0.0031	CbGpPWpGaD
Ganciclovir—SLC22A7—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	6.24e-05	0.00294	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—RRAS—prostate cancer	6.1e-05	0.00287	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—PLCB2—prostate cancer	6.03e-05	0.00284	CbGpPWpGaD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	6e-05	0.00283	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC39A1—prostate cancer	5.81e-05	0.00274	CbGpPWpGaD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC22A3—prostate cancer	5.72e-05	0.0027	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC7A1—prostate cancer	5.71e-05	0.00269	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—CYP7B1—prostate cancer	5.67e-05	0.00267	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC12A2—prostate cancer	5.53e-05	0.0026	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC26A4—prostate cancer	5.53e-05	0.0026	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—GNG5—prostate cancer	5.47e-05	0.00258	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC22A3—prostate cancer	5.33e-05	0.00251	CbGpPWpGaD
Ganciclovir—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	5.25e-05	0.00247	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—ABCG5—prostate cancer	4.92e-05	0.00232	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—ACHE—prostate cancer	4.88e-05	0.0023	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—CYP7B1—prostate cancer	4.73e-05	0.00223	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—PRKACB—prostate cancer	4.66e-05	0.0022	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—PLCB2—prostate cancer	4.62e-05	0.00218	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC12A2—prostate cancer	4.61e-05	0.00217	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC26A4—prostate cancer	4.61e-05	0.00217	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC39A1—prostate cancer	4.51e-05	0.00213	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC22A3—prostate cancer	4.48e-05	0.00211	CbGpPWpGaD
Ganciclovir—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	4.38e-05	0.00206	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC22A1—prostate cancer	4.35e-05	0.00205	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—GNG5—prostate cancer	4.19e-05	0.00198	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—ABCG5—prostate cancer	4.14e-05	0.00195	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—GNG5—prostate cancer	4.14e-05	0.00195	CbGpPWpGaD
Ganciclovir—Convulsion—Prednisone—prostate cancer	3.76e-05	0.000156	CcSEcCtD
Ganciclovir—Visual impairment—Epirubicin—prostate cancer	3.76e-05	0.000156	CcSEcCtD
Ganciclovir—Agranulocytosis—Doxorubicin—prostate cancer	3.75e-05	0.000156	CcSEcCtD
Ganciclovir—Hypertension—Prednisone—prostate cancer	3.75e-05	0.000155	CcSEcCtD
Ganciclovir—Rash—Mitoxantrone—prostate cancer	3.75e-05	0.000155	CcSEcCtD
Ganciclovir—Dermatitis—Mitoxantrone—prostate cancer	3.75e-05	0.000155	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.75e-05	0.000155	CcSEcCtD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC22A3—prostate cancer	3.74e-05	0.00176	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—ACHE—prostate cancer	3.74e-05	0.00176	CbGpPWpGaD
Ganciclovir—Headache—Mitoxantrone—prostate cancer	3.73e-05	0.000154	CcSEcCtD
Ganciclovir—Hypotension—Capecitabine—prostate cancer	3.72e-05	0.000154	CcSEcCtD
Ganciclovir—Insomnia—Docetaxel—prostate cancer	3.72e-05	0.000154	CcSEcCtD
Ganciclovir—Arthralgia—Prednisone—prostate cancer	3.7e-05	0.000153	CcSEcCtD
Ganciclovir—Myalgia—Prednisone—prostate cancer	3.7e-05	0.000153	CcSEcCtD
Ganciclovir—Paraesthesia—Docetaxel—prostate cancer	3.69e-05	0.000153	CcSEcCtD
Ganciclovir—Erythema multiforme—Epirubicin—prostate cancer	3.69e-05	0.000153	CcSEcCtD
Ganciclovir—Anxiety—Prednisone—prostate cancer	3.69e-05	0.000153	CcSEcCtD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—CYP7B1—prostate cancer	3.68e-05	0.00173	CbGpPWpGaD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	3.67e-05	0.000152	CcSEcCtD
Ganciclovir—Dyspnoea—Docetaxel—prostate cancer	3.67e-05	0.000152	CcSEcCtD
Ganciclovir—Somnolence—Docetaxel—prostate cancer	3.66e-05	0.000152	CcSEcCtD
Ganciclovir—Discomfort—Prednisone—prostate cancer	3.65e-05	0.000151	CcSEcCtD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC22A1—prostate cancer	3.65e-05	0.00172	CbGpPWpGaD
Ganciclovir—Hypersensitivity—Etoposide—prostate cancer	3.64e-05	0.000151	CcSEcCtD
Ganciclovir—Tinnitus—Epirubicin—prostate cancer	3.64e-05	0.000151	CcSEcCtD
Ganciclovir—Haemoglobin—Doxorubicin—prostate cancer	3.63e-05	0.00015	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Capecitabine—prostate cancer	3.63e-05	0.00015	CcSEcCtD
Ganciclovir—Rhinitis—Doxorubicin—prostate cancer	3.62e-05	0.00015	CcSEcCtD
Ganciclovir—Dyspepsia—Docetaxel—prostate cancer	3.62e-05	0.00015	CcSEcCtD
Ganciclovir—Haemorrhage—Doxorubicin—prostate cancer	3.61e-05	0.00015	CcSEcCtD
Ganciclovir—Hepatitis—Doxorubicin—prostate cancer	3.61e-05	0.00015	CcSEcCtD
Ganciclovir—Insomnia—Capecitabine—prostate cancer	3.6e-05	0.000149	CcSEcCtD
Ganciclovir—Hypoaesthesia—Doxorubicin—prostate cancer	3.59e-05	0.000149	CcSEcCtD
Ganciclovir—Pharyngitis—Doxorubicin—prostate cancer	3.58e-05	0.000149	CcSEcCtD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC26A4—prostate cancer	3.58e-05	0.00169	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC12A2—prostate cancer	3.58e-05	0.00169	CbGpPWpGaD
Ganciclovir—Paraesthesia—Capecitabine—prostate cancer	3.57e-05	0.000148	CcSEcCtD
Ganciclovir—Decreased appetite—Docetaxel—prostate cancer	3.57e-05	0.000148	CcSEcCtD
Ganciclovir—SLC22A1—Neuronal System—PRKACB—prostate cancer	3.57e-05	0.00168	CbGpPWpGaD
Ganciclovir—Urinary tract disorder—Doxorubicin—prostate cancer	3.57e-05	0.000148	CcSEcCtD
Ganciclovir—Oedema peripheral—Doxorubicin—prostate cancer	3.56e-05	0.000147	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Docetaxel—prostate cancer	3.55e-05	0.000147	CcSEcCtD
Ganciclovir—Asthenia—Etoposide—prostate cancer	3.55e-05	0.000147	CcSEcCtD
Ganciclovir—Connective tissue disorder—Doxorubicin—prostate cancer	3.55e-05	0.000147	CcSEcCtD
Ganciclovir—Dyspnoea—Capecitabine—prostate cancer	3.55e-05	0.000147	CcSEcCtD
Ganciclovir—Anaphylactic shock—Prednisone—prostate cancer	3.55e-05	0.000147	CcSEcCtD
Ganciclovir—Oedema—Prednisone—prostate cancer	3.55e-05	0.000147	CcSEcCtD
Ganciclovir—Fatigue—Docetaxel—prostate cancer	3.54e-05	0.000147	CcSEcCtD
Ganciclovir—Angiopathy—Epirubicin—prostate cancer	3.54e-05	0.000147	CcSEcCtD
Ganciclovir—Urethral disorder—Doxorubicin—prostate cancer	3.54e-05	0.000147	CcSEcCtD
Ganciclovir—Nausea—Mitoxantrone—prostate cancer	3.53e-05	0.000146	CcSEcCtD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—PRKACB—prostate cancer	3.53e-05	0.00166	CbGpPWpGaD
Ganciclovir—Infection—Prednisone—prostate cancer	3.52e-05	0.000146	CcSEcCtD
Ganciclovir—Mediastinal disorder—Epirubicin—prostate cancer	3.52e-05	0.000146	CcSEcCtD
Ganciclovir—Constipation—Docetaxel—prostate cancer	3.52e-05	0.000146	CcSEcCtD
Ganciclovir—Pain—Docetaxel—prostate cancer	3.52e-05	0.000146	CcSEcCtD
Ganciclovir—Dyspepsia—Capecitabine—prostate cancer	3.5e-05	0.000145	CcSEcCtD
Ganciclovir—Chills—Epirubicin—prostate cancer	3.5e-05	0.000145	CcSEcCtD
Ganciclovir—Pruritus—Etoposide—prostate cancer	3.5e-05	0.000145	CcSEcCtD
Ganciclovir—Arrhythmia—Epirubicin—prostate cancer	3.49e-05	0.000145	CcSEcCtD
Ganciclovir—Visual impairment—Doxorubicin—prostate cancer	3.48e-05	0.000144	CcSEcCtD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—GNG5—prostate cancer	3.48e-05	0.00164	CbGpPWpGaD
Ganciclovir—Tachycardia—Prednisone—prostate cancer	3.46e-05	0.000143	CcSEcCtD
Ganciclovir—Decreased appetite—Capecitabine—prostate cancer	3.46e-05	0.000143	CcSEcCtD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—ABCG5—prostate cancer	3.45e-05	0.00163	CbGpPWpGaD
Ganciclovir—Alopecia—Epirubicin—prostate cancer	3.45e-05	0.000143	CcSEcCtD
Ganciclovir—Skin disorder—Prednisone—prostate cancer	3.44e-05	0.000143	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Capecitabine—prostate cancer	3.44e-05	0.000142	CcSEcCtD
Ganciclovir—Fatigue—Capecitabine—prostate cancer	3.43e-05	0.000142	CcSEcCtD
Ganciclovir—Hyperhidrosis—Prednisone—prostate cancer	3.43e-05	0.000142	CcSEcCtD
Ganciclovir—Mental disorder—Epirubicin—prostate cancer	3.42e-05	0.000142	CcSEcCtD
Ganciclovir—Erythema multiforme—Doxorubicin—prostate cancer	3.41e-05	0.000142	CcSEcCtD
Ganciclovir—Constipation—Capecitabine—prostate cancer	3.4e-05	0.000141	CcSEcCtD
Ganciclovir—Pain—Capecitabine—prostate cancer	3.4e-05	0.000141	CcSEcCtD
Ganciclovir—SLC22A1—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	3.4e-05	0.0016	CbGpPWpGaD
Ganciclovir—Malnutrition—Epirubicin—prostate cancer	3.4e-05	0.000141	CcSEcCtD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—COMT—prostate cancer	3.4e-05	0.0016	CbGpPWpGaD
Ganciclovir—Feeling abnormal—Docetaxel—prostate cancer	3.39e-05	0.00014	CcSEcCtD
Ganciclovir—Diarrhoea—Etoposide—prostate cancer	3.39e-05	0.00014	CcSEcCtD
Ganciclovir—Anorexia—Prednisone—prostate cancer	3.38e-05	0.00014	CcSEcCtD
Ganciclovir—Tinnitus—Doxorubicin—prostate cancer	3.37e-05	0.00014	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Docetaxel—prostate cancer	3.36e-05	0.000139	CcSEcCtD
Ganciclovir—Flatulence—Epirubicin—prostate cancer	3.35e-05	0.000139	CcSEcCtD
Ganciclovir—Tension—Epirubicin—prostate cancer	3.33e-05	0.000138	CcSEcCtD
Ganciclovir—Dysgeusia—Epirubicin—prostate cancer	3.33e-05	0.000138	CcSEcCtD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—NCOA2—prostate cancer	3.32e-05	0.00157	CbGpPWpGaD
Ganciclovir—Nervousness—Epirubicin—prostate cancer	3.3e-05	0.000137	CcSEcCtD
Ganciclovir—Back pain—Epirubicin—prostate cancer	3.29e-05	0.000136	CcSEcCtD
Ganciclovir—Feeling abnormal—Capecitabine—prostate cancer	3.28e-05	0.000136	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—HAO1—prostate cancer	3.28e-05	0.00155	CbGpPWpGaD
Ganciclovir—Angiopathy—Doxorubicin—prostate cancer	3.28e-05	0.000136	CcSEcCtD
Ganciclovir—Dizziness—Etoposide—prostate cancer	3.27e-05	0.000136	CcSEcCtD
Ganciclovir—Muscle spasms—Epirubicin—prostate cancer	3.27e-05	0.000135	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Capecitabine—prostate cancer	3.26e-05	0.000135	CcSEcCtD
Ganciclovir—Mediastinal disorder—Doxorubicin—prostate cancer	3.26e-05	0.000135	CcSEcCtD
Ganciclovir—Body temperature increased—Docetaxel—prostate cancer	3.25e-05	0.000135	CcSEcCtD
Ganciclovir—Abdominal pain—Docetaxel—prostate cancer	3.25e-05	0.000135	CcSEcCtD
Ganciclovir—Chills—Doxorubicin—prostate cancer	3.24e-05	0.000134	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Prednisone—prostate cancer	3.23e-05	0.000134	CcSEcCtD
Ganciclovir—Arrhythmia—Doxorubicin—prostate cancer	3.23e-05	0.000134	CcSEcCtD
Ganciclovir—Insomnia—Prednisone—prostate cancer	3.21e-05	0.000133	CcSEcCtD
Ganciclovir—Vision blurred—Epirubicin—prostate cancer	3.2e-05	0.000133	CcSEcCtD
Ganciclovir—Alopecia—Doxorubicin—prostate cancer	3.19e-05	0.000132	CcSEcCtD
Ganciclovir—Paraesthesia—Prednisone—prostate cancer	3.18e-05	0.000132	CcSEcCtD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—SLC5A5—prostate cancer	3.17e-05	0.00149	CbGpPWpGaD
Ganciclovir—Mental disorder—Doxorubicin—prostate cancer	3.16e-05	0.000131	CcSEcCtD
Ganciclovir—Urticaria—Capecitabine—prostate cancer	3.16e-05	0.000131	CcSEcCtD
Ganciclovir—Ill-defined disorder—Epirubicin—prostate cancer	3.15e-05	0.000131	CcSEcCtD
Ganciclovir—Body temperature increased—Capecitabine—prostate cancer	3.15e-05	0.00013	CcSEcCtD
Ganciclovir—Abdominal pain—Capecitabine—prostate cancer	3.15e-05	0.00013	CcSEcCtD
Ganciclovir—Vomiting—Etoposide—prostate cancer	3.15e-05	0.00013	CcSEcCtD
Ganciclovir—Malnutrition—Doxorubicin—prostate cancer	3.14e-05	0.00013	CcSEcCtD
Ganciclovir—Anaemia—Epirubicin—prostate cancer	3.14e-05	0.00013	CcSEcCtD
Ganciclovir—Agitation—Epirubicin—prostate cancer	3.12e-05	0.000129	CcSEcCtD
Ganciclovir—Dyspepsia—Prednisone—prostate cancer	3.12e-05	0.000129	CcSEcCtD
Ganciclovir—Rash—Etoposide—prostate cancer	3.12e-05	0.000129	CcSEcCtD
Ganciclovir—Dermatitis—Etoposide—prostate cancer	3.12e-05	0.000129	CcSEcCtD
Ganciclovir—Headache—Etoposide—prostate cancer	3.1e-05	0.000128	CcSEcCtD
Ganciclovir—Flatulence—Doxorubicin—prostate cancer	3.1e-05	0.000128	CcSEcCtD
Ganciclovir—Tension—Doxorubicin—prostate cancer	3.09e-05	0.000128	CcSEcCtD
Ganciclovir—Decreased appetite—Prednisone—prostate cancer	3.08e-05	0.000128	CcSEcCtD
Ganciclovir—Dysgeusia—Doxorubicin—prostate cancer	3.08e-05	0.000128	CcSEcCtD
Ganciclovir—Malaise—Epirubicin—prostate cancer	3.06e-05	0.000127	CcSEcCtD
Ganciclovir—Fatigue—Prednisone—prostate cancer	3.06e-05	0.000127	CcSEcCtD
Ganciclovir—Nervousness—Doxorubicin—prostate cancer	3.05e-05	0.000127	CcSEcCtD
Ganciclovir—Vertigo—Epirubicin—prostate cancer	3.05e-05	0.000127	CcSEcCtD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC22A1—prostate cancer	3.05e-05	0.00144	CbGpPWpGaD
Ganciclovir—Leukopenia—Epirubicin—prostate cancer	3.04e-05	0.000126	CcSEcCtD
Ganciclovir—Back pain—Doxorubicin—prostate cancer	3.04e-05	0.000126	CcSEcCtD
Ganciclovir—Constipation—Prednisone—prostate cancer	3.03e-05	0.000126	CcSEcCtD
Ganciclovir—Hypersensitivity—Docetaxel—prostate cancer	3.03e-05	0.000126	CcSEcCtD
Ganciclovir—Muscle spasms—Doxorubicin—prostate cancer	3.02e-05	0.000125	CcSEcCtD
Ganciclovir—Cough—Epirubicin—prostate cancer	2.97e-05	0.000123	CcSEcCtD
Ganciclovir—Vision blurred—Doxorubicin—prostate cancer	2.96e-05	0.000123	CcSEcCtD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—PRKACB—prostate cancer	2.96e-05	0.0014	CbGpPWpGaD
Ganciclovir—Asthenia—Docetaxel—prostate cancer	2.95e-05	0.000122	CcSEcCtD
Ganciclovir—Convulsion—Epirubicin—prostate cancer	2.94e-05	0.000122	CcSEcCtD
Ganciclovir—Nausea—Etoposide—prostate cancer	2.94e-05	0.000122	CcSEcCtD
Ganciclovir—Hypertension—Epirubicin—prostate cancer	2.93e-05	0.000122	CcSEcCtD
Ganciclovir—Hypersensitivity—Capecitabine—prostate cancer	2.93e-05	0.000122	CcSEcCtD
Ganciclovir—Feeling abnormal—Prednisone—prostate cancer	2.92e-05	0.000121	CcSEcCtD
Ganciclovir—Ill-defined disorder—Doxorubicin—prostate cancer	2.92e-05	0.000121	CcSEcCtD
Ganciclovir—Pruritus—Docetaxel—prostate cancer	2.91e-05	0.000121	CcSEcCtD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC22A3—prostate cancer	2.91e-05	0.00137	CbGpPWpGaD
Ganciclovir—Anaemia—Doxorubicin—prostate cancer	2.91e-05	0.00012	CcSEcCtD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—GNG5—prostate cancer	2.9e-05	0.00137	CbGpPWpGaD
Ganciclovir—Gastrointestinal pain—Prednisone—prostate cancer	2.9e-05	0.00012	CcSEcCtD
Ganciclovir—Myalgia—Epirubicin—prostate cancer	2.89e-05	0.00012	CcSEcCtD
Ganciclovir—Chest pain—Epirubicin—prostate cancer	2.89e-05	0.00012	CcSEcCtD
Ganciclovir—Arthralgia—Epirubicin—prostate cancer	2.89e-05	0.00012	CcSEcCtD
Ganciclovir—Agitation—Doxorubicin—prostate cancer	2.89e-05	0.00012	CcSEcCtD
Ganciclovir—Anxiety—Epirubicin—prostate cancer	2.88e-05	0.00012	CcSEcCtD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	2.87e-05	0.000119	CcSEcCtD
Ganciclovir—Discomfort—Epirubicin—prostate cancer	2.86e-05	0.000118	CcSEcCtD
Ganciclovir—Asthenia—Capecitabine—prostate cancer	2.86e-05	0.000118	CcSEcCtD
Ganciclovir—Malaise—Doxorubicin—prostate cancer	2.84e-05	0.000118	CcSEcCtD
Ganciclovir—Dry mouth—Epirubicin—prostate cancer	2.83e-05	0.000117	CcSEcCtD
Ganciclovir—Vertigo—Doxorubicin—prostate cancer	2.82e-05	0.000117	CcSEcCtD
Ganciclovir—Urticaria—Prednisone—prostate cancer	2.82e-05	0.000117	CcSEcCtD
Ganciclovir—Pruritus—Capecitabine—prostate cancer	2.82e-05	0.000117	CcSEcCtD
Ganciclovir—Leukopenia—Doxorubicin—prostate cancer	2.81e-05	0.000117	CcSEcCtD
Ganciclovir—Diarrhoea—Docetaxel—prostate cancer	2.81e-05	0.000117	CcSEcCtD
Ganciclovir—Body temperature increased—Prednisone—prostate cancer	2.8e-05	0.000116	CcSEcCtD
Ganciclovir—Abdominal pain—Prednisone—prostate cancer	2.8e-05	0.000116	CcSEcCtD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—NCOA1—prostate cancer	2.8e-05	0.00132	CbGpPWpGaD
Ganciclovir—Confusional state—Epirubicin—prostate cancer	2.8e-05	0.000116	CcSEcCtD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—NCOA2—prostate cancer	2.79e-05	0.00132	CbGpPWpGaD
Ganciclovir—Anaphylactic shock—Epirubicin—prostate cancer	2.77e-05	0.000115	CcSEcCtD
Ganciclovir—Oedema—Epirubicin—prostate cancer	2.77e-05	0.000115	CcSEcCtD
Ganciclovir—Infection—Epirubicin—prostate cancer	2.76e-05	0.000114	CcSEcCtD
Ganciclovir—Cough—Doxorubicin—prostate cancer	2.74e-05	0.000114	CcSEcCtD
Ganciclovir—Convulsion—Doxorubicin—prostate cancer	2.72e-05	0.000113	CcSEcCtD
Ganciclovir—Diarrhoea—Capecitabine—prostate cancer	2.72e-05	0.000113	CcSEcCtD
Ganciclovir—Dizziness—Docetaxel—prostate cancer	2.72e-05	0.000113	CcSEcCtD
Ganciclovir—Thrombocytopenia—Epirubicin—prostate cancer	2.72e-05	0.000113	CcSEcCtD
Ganciclovir—Hypertension—Doxorubicin—prostate cancer	2.71e-05	0.000113	CcSEcCtD
Ganciclovir—Tachycardia—Epirubicin—prostate cancer	2.71e-05	0.000112	CcSEcCtD
Ganciclovir—Skin disorder—Epirubicin—prostate cancer	2.69e-05	0.000112	CcSEcCtD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—ABCG5—prostate cancer	2.68e-05	0.00126	CbGpPWpGaD
Ganciclovir—Hyperhidrosis—Epirubicin—prostate cancer	2.68e-05	0.000111	CcSEcCtD
Ganciclovir—Arthralgia—Doxorubicin—prostate cancer	2.68e-05	0.000111	CcSEcCtD
Ganciclovir—Chest pain—Doxorubicin—prostate cancer	2.68e-05	0.000111	CcSEcCtD
Ganciclovir—Myalgia—Doxorubicin—prostate cancer	2.68e-05	0.000111	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—ADI1—prostate cancer	2.67e-05	0.00126	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CBR1—prostate cancer	2.67e-05	0.00126	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CSAD—prostate cancer	2.67e-05	0.00126	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GRHL1—prostate cancer	2.67e-05	0.00126	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—TST—prostate cancer	2.67e-05	0.00126	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PSAT1—prostate cancer	2.67e-05	0.00126	CbGpPWpGaD
Ganciclovir—Anxiety—Doxorubicin—prostate cancer	2.67e-05	0.000111	CcSEcCtD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—SLC5A5—prostate cancer	2.67e-05	0.00126	CbGpPWpGaD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—RXRA—prostate cancer	2.66e-05	0.00126	CbGpPWpGaD
Ganciclovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	2.66e-05	0.00011	CcSEcCtD
Ganciclovir—Discomfort—Doxorubicin—prostate cancer	2.64e-05	0.00011	CcSEcCtD
Ganciclovir—Anorexia—Epirubicin—prostate cancer	2.64e-05	0.00011	CcSEcCtD
Ganciclovir—Dizziness—Capecitabine—prostate cancer	2.63e-05	0.000109	CcSEcCtD
Ganciclovir—Dry mouth—Doxorubicin—prostate cancer	2.62e-05	0.000109	CcSEcCtD
Ganciclovir—Vomiting—Docetaxel—prostate cancer	2.61e-05	0.000108	CcSEcCtD
Ganciclovir—Hypersensitivity—Prednisone—prostate cancer	2.61e-05	0.000108	CcSEcCtD
Ganciclovir—SLC22A1—Neuronal System—COMT—prostate cancer	2.6e-05	0.00123	CbGpPWpGaD
Ganciclovir—Rash—Docetaxel—prostate cancer	2.59e-05	0.000107	CcSEcCtD
Ganciclovir—Hypotension—Epirubicin—prostate cancer	2.59e-05	0.000107	CcSEcCtD
Ganciclovir—Dermatitis—Docetaxel—prostate cancer	2.59e-05	0.000107	CcSEcCtD
Ganciclovir—Confusional state—Doxorubicin—prostate cancer	2.59e-05	0.000107	CcSEcCtD
Ganciclovir—Headache—Docetaxel—prostate cancer	2.58e-05	0.000107	CcSEcCtD
Ganciclovir—Anaphylactic shock—Doxorubicin—prostate cancer	2.57e-05	0.000106	CcSEcCtD
Ganciclovir—Oedema—Doxorubicin—prostate cancer	2.57e-05	0.000106	CcSEcCtD
Ganciclovir—Infection—Doxorubicin—prostate cancer	2.55e-05	0.000106	CcSEcCtD
Ganciclovir—Asthenia—Prednisone—prostate cancer	2.54e-05	0.000105	CcSEcCtD
Ganciclovir—Vomiting—Capecitabine—prostate cancer	2.53e-05	0.000105	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.53e-05	0.000105	CcSEcCtD
Ganciclovir—Thrombocytopenia—Doxorubicin—prostate cancer	2.51e-05	0.000104	CcSEcCtD
Ganciclovir—Rash—Capecitabine—prostate cancer	2.51e-05	0.000104	CcSEcCtD
Ganciclovir—Pruritus—Prednisone—prostate cancer	2.51e-05	0.000104	CcSEcCtD
Ganciclovir—Insomnia—Epirubicin—prostate cancer	2.51e-05	0.000104	CcSEcCtD
Ganciclovir—Dermatitis—Capecitabine—prostate cancer	2.51e-05	0.000104	CcSEcCtD
Ganciclovir—Tachycardia—Doxorubicin—prostate cancer	2.5e-05	0.000104	CcSEcCtD
Ganciclovir—Headache—Capecitabine—prostate cancer	2.49e-05	0.000103	CcSEcCtD
Ganciclovir—Skin disorder—Doxorubicin—prostate cancer	2.49e-05	0.000103	CcSEcCtD
Ganciclovir—Paraesthesia—Epirubicin—prostate cancer	2.49e-05	0.000103	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—CKMT2—prostate cancer	2.48e-05	0.00117	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—UGT2B15—prostate cancer	2.48e-05	0.00117	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GRHPR—prostate cancer	2.48e-05	0.00117	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—UGT2B17—prostate cancer	2.48e-05	0.00117	CbGpPWpGaD
Ganciclovir—Hyperhidrosis—Doxorubicin—prostate cancer	2.48e-05	0.000103	CcSEcCtD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—PRKACB—prostate cancer	2.47e-05	0.00117	CbGpPWpGaD
Ganciclovir—Dyspnoea—Epirubicin—prostate cancer	2.47e-05	0.000102	CcSEcCtD
Ganciclovir—Somnolence—Epirubicin—prostate cancer	2.47e-05	0.000102	CcSEcCtD
Ganciclovir—Anorexia—Doxorubicin—prostate cancer	2.45e-05	0.000101	CcSEcCtD
Ganciclovir—Nausea—Docetaxel—prostate cancer	2.44e-05	0.000101	CcSEcCtD
Ganciclovir—Dyspepsia—Epirubicin—prostate cancer	2.44e-05	0.000101	CcSEcCtD
Ganciclovir—Diarrhoea—Prednisone—prostate cancer	2.43e-05	0.000101	CcSEcCtD
Ganciclovir—Decreased appetite—Epirubicin—prostate cancer	2.41e-05	9.99e-05	CcSEcCtD
Ganciclovir—Hypotension—Doxorubicin—prostate cancer	2.4e-05	9.94e-05	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Epirubicin—prostate cancer	2.39e-05	9.92e-05	CcSEcCtD
Ganciclovir—Fatigue—Epirubicin—prostate cancer	2.39e-05	9.91e-05	CcSEcCtD
Ganciclovir—Pain—Epirubicin—prostate cancer	2.37e-05	9.83e-05	CcSEcCtD
Ganciclovir—Constipation—Epirubicin—prostate cancer	2.37e-05	9.83e-05	CcSEcCtD
Ganciclovir—Nausea—Capecitabine—prostate cancer	2.36e-05	9.8e-05	CcSEcCtD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—NCOA1—prostate cancer	2.35e-05	0.00111	CbGpPWpGaD
Ganciclovir—Dizziness—Prednisone—prostate cancer	2.34e-05	9.72e-05	CcSEcCtD
Ganciclovir—Musculoskeletal discomfort—Doxorubicin—prostate cancer	2.34e-05	9.69e-05	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—RFK—prostate cancer	2.34e-05	0.0011	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—SULT2B1—prostate cancer	2.34e-05	0.0011	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PGAM2—prostate cancer	2.34e-05	0.0011	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—MBTPS1—prostate cancer	2.34e-05	0.0011	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—NAGLU—prostate cancer	2.34e-05	0.0011	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GSTM3—prostate cancer	2.34e-05	0.0011	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—AOX1—prostate cancer	2.34e-05	0.0011	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—NCOA2—prostate cancer	2.33e-05	0.0011	CbGpPWpGaD
Ganciclovir—Insomnia—Doxorubicin—prostate cancer	2.32e-05	9.62e-05	CcSEcCtD
Ganciclovir—Paraesthesia—Doxorubicin—prostate cancer	2.3e-05	9.55e-05	CcSEcCtD
Ganciclovir—Dyspnoea—Doxorubicin—prostate cancer	2.29e-05	9.48e-05	CcSEcCtD
Ganciclovir—Feeling abnormal—Epirubicin—prostate cancer	2.29e-05	9.47e-05	CcSEcCtD
Ganciclovir—Somnolence—Doxorubicin—prostate cancer	2.28e-05	9.46e-05	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Epirubicin—prostate cancer	2.27e-05	9.4e-05	CcSEcCtD
Ganciclovir—Dyspepsia—Doxorubicin—prostate cancer	2.26e-05	9.36e-05	CcSEcCtD
Ganciclovir—Vomiting—Prednisone—prostate cancer	2.25e-05	9.35e-05	CcSEcCtD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—GNG5—prostate cancer	2.25e-05	0.00106	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—RXRA—prostate cancer	2.24e-05	0.00106	CbGpPWpGaD
Ganciclovir—Rash—Prednisone—prostate cancer	2.24e-05	9.27e-05	CcSEcCtD
Ganciclovir—Dermatitis—Prednisone—prostate cancer	2.23e-05	9.26e-05	CcSEcCtD
Ganciclovir—Decreased appetite—Doxorubicin—prostate cancer	2.23e-05	9.25e-05	CcSEcCtD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—SLC5A5—prostate cancer	2.22e-05	0.00105	CbGpPWpGaD
Ganciclovir—Headache—Prednisone—prostate cancer	2.22e-05	9.21e-05	CcSEcCtD
Ganciclovir—Gastrointestinal disorder—Doxorubicin—prostate cancer	2.22e-05	9.18e-05	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—SRD5A2—prostate cancer	2.21e-05	0.00104	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—DEGS1—prostate cancer	2.21e-05	0.00104	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CYP3A43—prostate cancer	2.21e-05	0.00104	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—AMACR—prostate cancer	2.21e-05	0.00104	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—NAT1—prostate cancer	2.21e-05	0.00104	CbGpPWpGaD
Ganciclovir—Fatigue—Doxorubicin—prostate cancer	2.21e-05	9.17e-05	CcSEcCtD
Ganciclovir—Urticaria—Epirubicin—prostate cancer	2.2e-05	9.13e-05	CcSEcCtD
Ganciclovir—Pain—Doxorubicin—prostate cancer	2.19e-05	9.1e-05	CcSEcCtD
Ganciclovir—Constipation—Doxorubicin—prostate cancer	2.19e-05	9.1e-05	CcSEcCtD
Ganciclovir—Body temperature increased—Epirubicin—prostate cancer	2.19e-05	9.09e-05	CcSEcCtD
Ganciclovir—Abdominal pain—Epirubicin—prostate cancer	2.19e-05	9.09e-05	CcSEcCtD
Ganciclovir—Feeling abnormal—Doxorubicin—prostate cancer	2.11e-05	8.77e-05	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—HSD17B1—prostate cancer	2.11e-05	0.000996	CbGpPWpGaD
Ganciclovir—Nausea—Prednisone—prostate cancer	2.11e-05	8.73e-05	CcSEcCtD
Ganciclovir—Gastrointestinal pain—Doxorubicin—prostate cancer	2.1e-05	8.7e-05	CcSEcCtD
Ganciclovir—Hypersensitivity—Epirubicin—prostate cancer	2.04e-05	8.47e-05	CcSEcCtD
Ganciclovir—Urticaria—Doxorubicin—prostate cancer	2.04e-05	8.45e-05	CcSEcCtD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—PPARA—prostate cancer	2.04e-05	0.000959	CbGpPWpGaD
Ganciclovir—Body temperature increased—Doxorubicin—prostate cancer	2.03e-05	8.41e-05	CcSEcCtD
Ganciclovir—Abdominal pain—Doxorubicin—prostate cancer	2.03e-05	8.41e-05	CcSEcCtD
Ganciclovir—Asthenia—Epirubicin—prostate cancer	1.99e-05	8.25e-05	CcSEcCtD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—NCOA1—prostate cancer	1.97e-05	0.000926	CbGpPWpGaD
Ganciclovir—Pruritus—Epirubicin—prostate cancer	1.96e-05	8.13e-05	CcSEcCtD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—PRKACB—prostate cancer	1.92e-05	0.000906	CbGpPWpGaD
Ganciclovir—Diarrhoea—Epirubicin—prostate cancer	1.9e-05	7.87e-05	CcSEcCtD
Ganciclovir—Hypersensitivity—Doxorubicin—prostate cancer	1.89e-05	7.84e-05	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—B4GALT4—prostate cancer	1.88e-05	0.000888	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—HPGD—prostate cancer	1.88e-05	0.000888	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—RXRA—prostate cancer	1.87e-05	0.000881	CbGpPWpGaD
Ganciclovir—Asthenia—Doxorubicin—prostate cancer	1.84e-05	7.63e-05	CcSEcCtD
Ganciclovir—Dizziness—Epirubicin—prostate cancer	1.83e-05	7.6e-05	CcSEcCtD
Ganciclovir—SLC22A1—Transmission across Chemical Synapses—MDM2—prostate cancer	1.82e-05	0.000856	CbGpPWpGaD
Ganciclovir—Pruritus—Doxorubicin—prostate cancer	1.82e-05	7.53e-05	CcSEcCtD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—NCOA2—prostate cancer	1.81e-05	0.000854	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—TNFRSF21—prostate cancer	1.77e-05	0.000834	CbGpPWpGaD
Ganciclovir—Vomiting—Epirubicin—prostate cancer	1.76e-05	7.31e-05	CcSEcCtD
Ganciclovir—Diarrhoea—Doxorubicin—prostate cancer	1.76e-05	7.28e-05	CcSEcCtD
Ganciclovir—Rash—Epirubicin—prostate cancer	1.75e-05	7.25e-05	CcSEcCtD
Ganciclovir—Dermatitis—Epirubicin—prostate cancer	1.75e-05	7.24e-05	CcSEcCtD
Ganciclovir—Headache—Epirubicin—prostate cancer	1.74e-05	7.2e-05	CcSEcCtD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	1.73e-05	0.000815	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CYP7B1—prostate cancer	1.72e-05	0.000812	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—MTAP—prostate cancer	1.72e-05	0.000812	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—PPARA—prostate cancer	1.71e-05	0.000806	CbGpPWpGaD
Ganciclovir—Dizziness—Doxorubicin—prostate cancer	1.7e-05	7.03e-05	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—SULT1E1—prostate cancer	1.68e-05	0.000791	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—SRD5A1—prostate cancer	1.68e-05	0.000791	CbGpPWpGaD
Ganciclovir—Nausea—Epirubicin—prostate cancer	1.65e-05	6.83e-05	CcSEcCtD
Ganciclovir—Vomiting—Doxorubicin—prostate cancer	1.63e-05	6.76e-05	CcSEcCtD
Ganciclovir—Rash—Doxorubicin—prostate cancer	1.62e-05	6.71e-05	CcSEcCtD
Ganciclovir—Dermatitis—Doxorubicin—prostate cancer	1.62e-05	6.7e-05	CcSEcCtD
Ganciclovir—SLC22A7—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.62e-05	0.000762	CbGpPWpGaD
Ganciclovir—Headache—Doxorubicin—prostate cancer	1.61e-05	6.66e-05	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—HSD17B3—prostate cancer	1.6e-05	0.000755	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ACSL4—prostate cancer	1.6e-05	0.000755	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—UMPS—prostate cancer	1.54e-05	0.000724	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PHGDH—prostate cancer	1.54e-05	0.000724	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ARG2—prostate cancer	1.54e-05	0.000724	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—NCOA1—prostate cancer	1.53e-05	0.00072	CbGpPWpGaD
Ganciclovir—Nausea—Doxorubicin—prostate cancer	1.52e-05	6.32e-05	CcSEcCtD
Ganciclovir—SLC22A1—Metabolism—LDHB—prostate cancer	1.51e-05	0.00071	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CYP3A5—prostate cancer	1.48e-05	0.000696	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—RXRA—prostate cancer	1.45e-05	0.000685	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—PPARA—prostate cancer	1.43e-05	0.000673	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PDHA1—prostate cancer	1.43e-05	0.000673	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—UCP3—prostate cancer	1.43e-05	0.000673	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GSTA3—prostate cancer	1.43e-05	0.000673	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—TCN2—prostate cancer	1.43e-05	0.000673	CbGpPWpGaD
Ganciclovir—SLC22A1—Neuronal System—MDM2—prostate cancer	1.39e-05	0.000656	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—SLC22A3—prostate cancer	1.36e-05	0.000642	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—HSD3B1—prostate cancer	1.36e-05	0.000642	CbGpPWpGaD
Ganciclovir—SLC22A8—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.36e-05	0.00064	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GSTA4—prostate cancer	1.31e-05	0.000615	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—TBXAS1—prostate cancer	1.31e-05	0.000615	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GSTA2—prostate cancer	1.27e-05	0.0006	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ABCG5—prostate cancer	1.26e-05	0.000592	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—SULT1A1—prostate cancer	1.26e-05	0.000592	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GSTA1—prostate cancer	1.23e-05	0.000578	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GSTO1—prostate cancer	1.21e-05	0.000572	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—NAT2—prostate cancer	1.21e-05	0.000572	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—HSD3B2—prostate cancer	1.21e-05	0.000572	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PLCB2—prostate cancer	1.16e-05	0.000548	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—LRP2—prostate cancer	1.16e-05	0.000548	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CYP2C18—prostate cancer	1.16e-05	0.000548	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—P4HB—prostate cancer	1.14e-05	0.000538	CbGpPWpGaD
Ganciclovir—SLC22A6—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.13e-05	0.000534	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—PPARA—prostate cancer	1.11e-05	0.000523	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—SULT2A1—prostate cancer	1.08e-05	0.00051	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—MED12—prostate cancer	1.06e-05	0.000502	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GNG5—prostate cancer	1.06e-05	0.000498	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—NCOA3—prostate cancer	1.02e-05	0.000479	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—HPGDS—prostate cancer	9.7e-06	0.000457	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CYP2C19—prostate cancer	9.64e-06	0.000454	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ACHE—prostate cancer	9.41e-06	0.000443	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GSTT1—prostate cancer	9.41e-06	0.000443	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CYP2A6—prostate cancer	9.3e-06	0.000438	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—AKR1C3—prostate cancer	9.05e-06	0.000426	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PRKACB—prostate cancer	9e-06	0.000424	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CYP17A1—prostate cancer	8.91e-06	0.00042	CbGpPWpGaD
Ganciclovir—SLC22A1—Transmembrane transport of small molecules—CREBBP—prostate cancer	8.81e-06	0.000415	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—NCOA2—prostate cancer	8.49e-06	0.0004	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—SLC5A5—prostate cancer	8.1e-06	0.000382	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CYP2E1—prostate cancer	7.91e-06	0.000373	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—NQO1—prostate cancer	7.82e-06	0.000369	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—TH—prostate cancer	7.71e-06	0.000363	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CYP3A4—prostate cancer	7.63e-06	0.000359	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CYP1B1—prostate cancer	7.5e-06	0.000353	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GGT1—prostate cancer	7.26e-06	0.000342	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—NCOA1—prostate cancer	7.15e-06	0.000337	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CYP19A1—prostate cancer	7.05e-06	0.000332	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—RXRA—prostate cancer	6.8e-06	0.000321	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—COMT—prostate cancer	6.55e-06	0.000309	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GSTP1—prostate cancer	6.52e-06	0.000307	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ITPR1—prostate cancer	6.42e-06	0.000302	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—TYMS—prostate cancer	6.06e-06	0.000286	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—GSTM1—prostate cancer	5.99e-06	0.000282	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—LPL—prostate cancer	5.88e-06	0.000277	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CYP1A1—prostate cancer	5.68e-06	0.000268	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—ERCC2—prostate cancer	5.64e-06	0.000266	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—MTHFR—prostate cancer	5.3e-06	0.00025	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PPARA—prostate cancer	5.2e-06	0.000245	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CAV1—prostate cancer	4.89e-06	0.00023	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PIK3CG—prostate cancer	4.45e-06	0.00021	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—INS—prostate cancer	4.21e-06	0.000199	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—CREBBP—prostate cancer	4.13e-06	0.000194	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PIK3CD—prostate cancer	3.91e-06	0.000184	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—NOS3—prostate cancer	3.69e-06	0.000174	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PIK3CB—prostate cancer	3.41e-06	0.000161	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PTGS2—prostate cancer	3.38e-06	0.000159	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PTEN—prostate cancer	2.95e-06	0.000139	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—EP300—prostate cancer	2.81e-06	0.000132	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—PIK3CA—prostate cancer	2.08e-06	9.8e-05	CbGpPWpGaD
Ganciclovir—SLC22A1—Metabolism—AKT1—prostate cancer	1.7e-06	8e-05	CbGpPWpGaD
